Glenmark gets tentative nod from USFDA for migraine tablets
Quotes

Glenmark gets tentative nod from USFDA for migraine tablets

Last Updated: Thursday, September 20, 2012, 12:57
 
 Comment 0
 
Glenmark gets tentative nod from USFDA for migraine tablets
New Delhi: Glenmark Pharmaceuticals on Thursday said it has received tentative approval from the US health regulator for its generic Rizatriptan Benzoate tablets used for treating migraine attacks.

The company's US arm Glenmark Generics Inc USA has received tentative approval for Rizatriptan Benzoate tablets from the US Food and Drug Administration (USFDA), Glenmark Pharmaceuticals said in a statement.

The tablets are generic version of drug major Merck's Maxalt tablets, it added.

Quoting IMS Health data, the company said Rizatriptan Benzoate immediate release tablets achieved sales of USD 315 million for the 12 month period ending June 2012.

Current portfolio of the company consists of 81 products authorised for distribution in the US market and 41 abbreviated new drug applications (ANDAs) pending approval with the USFDA.

Shares of Glenmark Pharmaceuticals were trading at Rs 416 per scrip on BSE in the afternoon trade, up 0.96 percent from its previous close.

PTI


First Published: Thursday, September 20, 2012, 12:57


Comments


comments powered by Disqus
World`s Top 10 Powerful Women
World`s Top 10 Powerful Women
New Age XUV500
New Age XUV500
Renault Kwid
Renault Kwid
Tata GenX Nano
Tata GenX Nano
2015 Indian Roadmaster
2015 Indian Roadmaster

Web Wrap
Contact Us : Privacy Policy : Legal Disclaimer
Copyright © Zee Media Corporation Ltd. All rights reserved